NBIX

Neurocrine Biosciences
D

NBIX

109.750
USD
3.13
(2.94%)
مغلق
حجم التداول
70,378
الربح لكل سهم
5
العائد الربحي
-
P/E
33
حجم السوق
10,858,471,182
أصول ذات صلة
ALNY
ALNY
3.98
(1.56%)
259.33 USD
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
A
ARWR
0.380
(2.71%)
14.410 USD
BIIB
BIIB
2.500
(2.07%)
123.460 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
ILMN
ILMN
1.395
(1.82%)
77.905 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
S
SGMO
-0.01210
(-1.63%)
0.72800 USD
S
SRPT
0.740
(1.18%)
63.550 USD
VRTX
VRTX
2.22
(0.45%)
500.92 USD
المزيد
الأخبار المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.